Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Using the Web-Based Double Eye Control Program on Medication of High Risk Drugs in Pediatric Patients: The Effect of Web-Based Double Eye Control Program

NCT06371690 is registered in ClinicalTrials.gov with Izmir Katip Celebi University as lead sponsor.

NCT NCT06371690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06371690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Using the Web-Based Double Eye Control Program on Medication of High Risk Drugs in Pediatric Patients: The Effect of Web-Based Double Eye Control Program
Lead sponsor
Izmir Katip Celebi University
Phase
Observational
Overall status
Completed
Start date
November 1, 2017
Completion date
September 30, 2018
Enrollment
1,070 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

main heading (descriptor) terms